Fann J I, Glower D D, Miller D C, Yun K L, Rankin J S, White W D, Smith R L, Wolfe W G, Shumway N E
Department of Cardiovascular Surgery, Stanford University School of Medicine, CA 94305-5247.
J Thorac Cardiovasc Surg. 1991 Jul;102(1):62-73; discussion 73-5.
Two hundred fifty-two patients underwent operation for type A aortic dissection at Stanford University Medical Center from 1963 to 1987 and Duke University Medical Center from 1975 to 1988. Sixty-seven percent had an acute type A dissection and 33% had a chronic type A dissection. In addition to repair or replacement of the ascending aorta, 121 patients (48%) required an aortic valve procedure. Valve resuspension was performed in 46 (39 acute type A and 7 chronic type A), with an operative mortality rate of 13% +/- 5% (+/- 70% confidence limits), and aortic valve replacement in 75 (36 acute type A and 39 chronic type A), with an operative mortality rate of 20% +/- 5% (p = not significant versus resuspension). The operative mortality rate for patients requiring only repair or replacement of the ascending aorta was 32% +/- 4%. Indications for valve replacement included coexistent (nonacute) aortic valve disease, Marfan's syndrome, annuloaortic ectasia, and cases in which successful resuspension could not be accomplished. The overall actuarial survival rate for all patients was 59% +/- 3% (+/- 1 standard error of the mean), 40% +/- 4%, and 25% +/- 5% at 5, 10, and 15 years, respectively. Survival rates at these same times for patients with valve resuspension were 67% +/- 8%, 52% +/- 10%, and 26% +/- 19%, respectively; for patients who required aortic valve replacement, these survival rates were 70% +/- 5%, 39% +/- 8%, and 21% +/- 11%; finally, patients who received only an ascending aortic procedure had survival probabilities of 51% +/- 5%, 37% +/- 6%, and 23% +/- 6% (p = not significant versus resuspension versus aortic valve replacement). Multivariate analysis showed advanced age (p less than 0.001), previous cardiac or aortic operation (p less than 0.001), more preoperative dissection complications (p = 0.002), and earlier operative date (p = 0.038) to be the only significant, independent factors that increased the likelihood of early or late death. The type of aortic valve procedure (resuspension versus aortic valve replacement versus none) was not a significant predictor of mortality. Two of 46 patients with valve resuspension required late aortic valve replacement (freedom from aortic valve replacement: 100% and 80% +/- 13% at 5 and 10 years, respectively), as did 4 of 75 patients with initial aortic valve replacement (freedom from repeat aortic valve replacement: 98% +/- 2% and 73% +/- 13%, respectively).(ABSTRACT TRUNCATED AT 400 WORDS)
1963年至1987年期间,斯坦福大学医学中心有252例患者接受了A型主动脉夹层手术;1975年至1988年期间,杜克大学医学中心也有患者接受了此类手术。67%的患者为急性A型夹层,33%为慢性A型夹层。除了修复或置换升主动脉外,121例患者(48%)还需要进行主动脉瓣手术。46例患者(39例急性A型和7例慢性A型)进行了瓣膜悬吊术,手术死亡率为13%±5%(±70%置信区间);75例患者(36例急性A型和39例慢性A型)进行了主动脉瓣置换术,手术死亡率为20%±5%(与瓣膜悬吊术相比,p值无统计学意义)。仅需修复或置换升主动脉的患者手术死亡率为32%±4%。瓣膜置换的指征包括并存(非急性)主动脉瓣疾病、马方综合征、主动脉瓣环扩张以及无法成功进行悬吊术的病例。所有患者的总体精算生存率在5年、10年和15年时分别为59%±3%、40%±4%和25%±5%。瓣膜悬吊术患者在相同时间的生存率分别为67%±8%、52%±10%和26%±19%;需要主动脉瓣置换的患者,这些生存率分别为70%±5%、39%±8%和21%±11%;最后,仅接受升主动脉手术的患者生存概率分别为51%±5%(p值与瓣膜悬吊术和主动脉瓣置换术相比无统计学意义)、37%±6%和23%±6%。多因素分析显示,高龄(p<0.001)、既往心脏或主动脉手术史(p<0.001)、术前更多的夹层并发症(p = 0.002)以及更早的手术日期(p = 0.038)是增加早期或晚期死亡可能性的唯一显著、独立因素。主动脉瓣手术类型(瓣膜悬吊术与主动脉瓣置换术与未进行手术)并非死亡率的显著预测因素。46例瓣膜悬吊术患者中有2例需要晚期主动脉瓣置换(5年和10年时无主动脉瓣置换的概率分别为100%和80%±13%),75例初始进行主动脉瓣置换的患者中有4例也需要再次置换(再次主动脉瓣置换的概率分别为98%±2%和73%±13%)。(摘要截选至400字)